Navigation Links
World's Leading Manufacturer of IV Solutions Chooses Three RIVA Systems
Date:2/17/2010

WINNIPEG, Feb. 17 /PRNewswire/ - Following the successful integration of RIVA (Robotic IV Automation System) - a self-contained unit for filling IV syringes and bags - into three healthcare institutions in 2009, and the announcements of several more sales for installation in 2010, medical device company Intelligent Hospital Systems has confirmed the sale of three additional RIVA systems for cytotoxic drug preparation in 2010. This sale was to a major worldwide medical products and services company, who have also indicated an interest in purchasing several more systems once RIVA is fully integrated into their operations.

This is the third multi-unit deal that Intelligent Hospital Systems has signed in recent months and with the latest announcement about proven performance of RIVA in the field, confidence in the ability of automation in the IV admixture space is growing.

In addition to expediting the compounding process and enhancing patient safety, RIVA has notably improved work and safety conditions for hospital staff, reducing their exposure to a multitude of drug compounds - namely cytotoxic drugs. "With increasing concern over potential cytotoxic drug harm to workers, automated systems like RIVA that reduce drug exposure become an increasingly viable technology," notes Dr. Niels Erik Hansen, Chief Executive Officer of IH Systems. The RIVA system enables automated compounding of individual patient doses of cytotoxic drugs into a range of diverse container forms including syringes and bags, which is key to supporting safe and flexible therapy.

For Jane Arnot, IH Systems VP Customer Sales and Service, the success of RIVA in day-to-day healthcare practices is key in growing confidence and support from directors of pharmacies worldwide. "Part of the reason that the RIVA system has been so effective is its flexibility in supporting hospitals' and pharmacies' broad base of drug compounds. The three RIVA systems in place are running at least 12 different drug compounds on a regular basis for both patient specific and batch preparations. RIVA is quickly becoming an integrated part of these healthcare institutions' operations," states Arnot. "We are also very excited about the interest that we have seen worldwide in the use of RIVA for both cytotoxic drug preparation as well as non-cytotoxic drug preparation. This speaks to the confidence that our customers have that RIVA will address the unique concerns and challenges in both of these diverse environments," concludes Arnot.

RIVA (Robotic IV Automation System) - a self-contained unit for filling IV syringes and bags - is the first product developed by Winnipeg-based medical device company Intelligent Hospital Systems. For more information, please visit www.rivasystem.com.

SOURCE Intelligent Hospital Systems Ltd.


'/>"/>
SOURCE Intelligent Hospital Systems Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Life Ionizers Drums to a New Beat with Julian Pavone, the Worlds Youngest Drummer and Inventor
2. Paging All Science and Medical Mavens: Get To Philadelphia Stat for Body Worlds and Beyond
3. BODY WORLDS Anatomical Exhibitions of Donor Bodies Receives 28 Millionth Visitor.
4. Variants of umami taste receptor contribute to our individualized flavor worlds
5. Scienceroll.com on the Medical Implications of Virtual Worlds
6. Gunther Von Hagens BODY WORLDS and KORPERWELTEN - Not Affiliated With Paris Copycat Display
7. BODY WORLDS Exhibition Uses Lung Specimens to Launch Anti-Smoking Campaign at the San Diego Natural History Museum
8. HHS AIDS.gov to Use Blogs, Virtual Worlds, and Social Networks to Deliver HIV Information for World AIDS Day 2008
9. Gunther von Hagens BODY WORLDS Exhibitions Welcome Specimens From Worlds First Living Body Donor for Plastination
10. Gunther Von Hagens BODY WORLDS Exhibitions Mark 25th Million Visitor Milestone
11. California Science Center Welcomes 1-Millionth BODY WORLDS Visitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Indianapolis, IN (PRWEB) , ... February 08, 2016 ... ... serving the Indianapolis, IN metro area, has selected the latest beneficiary of their ... nonprofit organization dedicated to preventing bullying in area schools. Donations are now being ...
(Date:2/8/2016)... ... ... Remember the old saying “rub some dirt on it”? Perhaps you should try using ... the health benefits of integrating clay into a daily diet are numerous, as clay ... speaker, Perry A~ has since dedicated her life to learning about the benefits of ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... greater than 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth ... ”It is time to make a change in public health,” states Carole Baggerly, ...
(Date:2/8/2016)... ... February 08, 2016 , ... Guruji Mahendra Kumar Trivedi is offering ... 2016 in honor of his birthday on February 10th. During this time, people ... is known by over 250,000 people from over 40 different countries as an “ordinary ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women's Excellence staff, in all four locations, wore ... Wear Red Day is the first Friday each February and a day to bring ... in 3 deaths among women each year – more than all cancers combined. Go ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Intarcia Therapeutics, Inc. today announced the appointment of ... created role of Vice President, Head of Global Medical ... of leadership experience at leading pharmaceutical, biotechnology, and health ... Most recently Dr. Yee served as VP, Head of ... Officer at AstraZeneca, where he led medical affairs across ...
(Date:2/8/2016)... BASEL , Switzerland and PALO ALTO, Calif. ... leader in biological and chemical manufacturing, and Kodiak Sciences ... for the treatment of retinal disease, announced today agreements ... the agreement, Lonza will manufacture material at multiple sites, ... --> --> Retinal ...
(Date:2/8/2016)... 2016 /PRNewswire/--  Cell Applications, Inc. and Cyfuse ... are now available in North America ... bioprinting approach called the "Kenzan Method." Utilizing Cyfuse ... state-of-the-art robotic system that fabricates 3D tissue from ... bio-printing model that makes scaffold-free tissue available immediately ...
Breaking Medicine Technology: